Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study

Christi A. Patten; Kathryn R. Koller; Christie A. Flanagan; Vanessa Y. Hiratsuka; Christine A. Hughes; Abbie W. Wolfe; Paul A. Decker; Kristin Fruth; Tabetha A. Brockman; Molly Korpela; Diana Gamez; Carrie Bronars; Neil J. Murphy; Dorothy Hatsukami; Neal L. Benowitz; Timothy K. Thomas

doi:10.1016/j.pec.2018.10.009

Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study

Christi A. Patten, Kathryn R. Koller, Christie A. Flanagan, Vanessa Y. Hiratsuka, Christine A. Hughes, Abbie W. Wolfe, Paul A. Decker, Kristin Fruth, Tabetha A. Brockman, Molly Korpela, Diana Gamez, Carrie Bronars, Neil J. Murphy, Dorothy Hatsukami, Neal L. Benowitz, Timothy K. Thomas

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Objective: There is some evidence for biomarker feedback when combined with cessation counseling for reducing smoking in pregnancy. This randomized controlled pilot study evaluated feasibility and potential efficacy of a social-cognitive theory (SCT)-based biomarker feedback intervention among pregnant Alaska Native (AN) smokers. Methods: Participants were randomly assigned to receive three study calls (10–20 min each): (1) biomarker feedback intervention (n = 30) including personalized cotinine results and feedback on their baby's likely exposure to carcinogen metabolite NNAL, or (2) contact control usual care condition based on the 5As (n = 30). Assessments were conducted at baseline, post-treatment, and delivery. Results: High rates of treatment compliance, study retention, and treatment acceptability were observed in both groups. 7-day point prevalence smoking abstinence rates at delivery verified with urinary cotinine were the same in both study groups (20% intent-to-treat analysis, 26% per-protocol). SCT-based measures did not change differentially from baseline by study group. Conclusion: This trial supports the feasibility and acceptability of providing biomarker feedback within the clinical care delivery system, but the intervention did not promote increased smoking cessation during pregnancy compared to usual care. Practice Implications: Efforts are needed to promote the usual care and to develop alternative biomarker feedback messaging for pregnant AN women.

Original language	English (US)
Pages (from-to)	528-535
Number of pages	8
Journal	Patient Education and Counseling
Volume	102
Issue number	3
DOIs	https://doi.org/10.1016/j.pec.2018.10.009
State	Published - Mar 2019

Bibliographical note

Funding Information:
This work was supported by the National Cancer Institute at the National Institutes of Health (grant number U54CA153605 ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funding source had no role in the study design; in collection, analysis, and interpretation of data; in writing the manuscript; or in the decision to submit the article for publication.

Publisher Copyright:
© 2018 The Authors

Keywords

Alaska Native
Biomarker feedback
Cigarette smoking
Intervention
Pregnancy
Smoking cessation

Publisher link

10.1016/j.pec.2018.10.009

Find It

Find It at U of M Libraries

Cite this

Patten, C. A., Koller, K. R., Flanagan, C. A., Hiratsuka, V. Y., Hughes, C. A., Wolfe, A. W., Decker, P. A., Fruth, K., Brockman, T. A., Korpela, M., Gamez, D., Bronars, C., Murphy, N. J., Hatsukami, D., Benowitz, N. L., & Thomas, T. K. (2019). Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study. Patient Education and Counseling, 102(3), 528-535. https://doi.org/10.1016/j.pec.2018.10.009

Patten, CA, Koller, KR, Flanagan, CA, Hiratsuka, VY, Hughes, CA, Wolfe, AW, Decker, PA, Fruth, K, Brockman, TA, Korpela, M, Gamez, D, Bronars, C, Murphy, NJ, Hatsukami, D, Benowitz, NL & Thomas, TK 2019, 'Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study', Patient Education and Counseling, vol. 102, no. 3, pp. 528-535. https://doi.org/10.1016/j.pec.2018.10.009

@article{748c8e73836b46fb83a83bc2834e499f,

title = "Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study",

abstract = "Objective: There is some evidence for biomarker feedback when combined with cessation counseling for reducing smoking in pregnancy. This randomized controlled pilot study evaluated feasibility and potential efficacy of a social-cognitive theory (SCT)-based biomarker feedback intervention among pregnant Alaska Native (AN) smokers. Methods: Participants were randomly assigned to receive three study calls (10–20 min each): (1) biomarker feedback intervention (n = 30) including personalized cotinine results and feedback on their baby's likely exposure to carcinogen metabolite NNAL, or (2) contact control usual care condition based on the 5As (n = 30). Assessments were conducted at baseline, post-treatment, and delivery. Results: High rates of treatment compliance, study retention, and treatment acceptability were observed in both groups. 7-day point prevalence smoking abstinence rates at delivery verified with urinary cotinine were the same in both study groups (20% intent-to-treat analysis, 26% per-protocol). SCT-based measures did not change differentially from baseline by study group. Conclusion: This trial supports the feasibility and acceptability of providing biomarker feedback within the clinical care delivery system, but the intervention did not promote increased smoking cessation during pregnancy compared to usual care. Practice Implications: Efforts are needed to promote the usual care and to develop alternative biomarker feedback messaging for pregnant AN women.",

keywords = "Alaska Native, Biomarker feedback, Cigarette smoking, Intervention, Pregnancy, Smoking cessation",

author = "Patten, {Christi A.} and Koller, {Kathryn R.} and Flanagan, {Christie A.} and Hiratsuka, {Vanessa Y.} and Hughes, {Christine A.} and Wolfe, {Abbie W.} and Decker, {Paul A.} and Kristin Fruth and Brockman, {Tabetha A.} and Molly Korpela and Diana Gamez and Carrie Bronars and Murphy, {Neil J.} and Dorothy Hatsukami and Benowitz, {Neal L.} and Thomas, {Timothy K.}",

note = "Funding Information: This work was supported by the National Cancer Institute at the National Institutes of Health (grant number U54CA153605 ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funding source had no role in the study design; in collection, analysis, and interpretation of data; in writing the manuscript; or in the decision to submit the article for publication. Publisher Copyright: {\textcopyright} 2018 The Authors",

year = "2019",

month = mar,

doi = "10.1016/j.pec.2018.10.009",

language = "English (US)",

volume = "102",

pages = "528--535",

journal = "Patient Education and Counseling",

issn = "0738-3991",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women

T2 - Randomized pilot study

AU - Patten, Christi A.

AU - Koller, Kathryn R.

AU - Flanagan, Christie A.

AU - Hiratsuka, Vanessa Y.

AU - Hughes, Christine A.

AU - Wolfe, Abbie W.

AU - Decker, Paul A.

AU - Fruth, Kristin

AU - Brockman, Tabetha A.

AU - Korpela, Molly

AU - Gamez, Diana

AU - Bronars, Carrie

AU - Murphy, Neil J.

AU - Hatsukami, Dorothy

AU - Benowitz, Neal L.

AU - Thomas, Timothy K.

N1 - Funding Information: This work was supported by the National Cancer Institute at the National Institutes of Health (grant number U54CA153605 ). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funding source had no role in the study design; in collection, analysis, and interpretation of data; in writing the manuscript; or in the decision to submit the article for publication. Publisher Copyright: © 2018 The Authors

PY - 2019/3

Y1 - 2019/3

N2 - Objective: There is some evidence for biomarker feedback when combined with cessation counseling for reducing smoking in pregnancy. This randomized controlled pilot study evaluated feasibility and potential efficacy of a social-cognitive theory (SCT)-based biomarker feedback intervention among pregnant Alaska Native (AN) smokers. Methods: Participants were randomly assigned to receive three study calls (10–20 min each): (1) biomarker feedback intervention (n = 30) including personalized cotinine results and feedback on their baby's likely exposure to carcinogen metabolite NNAL, or (2) contact control usual care condition based on the 5As (n = 30). Assessments were conducted at baseline, post-treatment, and delivery. Results: High rates of treatment compliance, study retention, and treatment acceptability were observed in both groups. 7-day point prevalence smoking abstinence rates at delivery verified with urinary cotinine were the same in both study groups (20% intent-to-treat analysis, 26% per-protocol). SCT-based measures did not change differentially from baseline by study group. Conclusion: This trial supports the feasibility and acceptability of providing biomarker feedback within the clinical care delivery system, but the intervention did not promote increased smoking cessation during pregnancy compared to usual care. Practice Implications: Efforts are needed to promote the usual care and to develop alternative biomarker feedback messaging for pregnant AN women.

AB - Objective: There is some evidence for biomarker feedback when combined with cessation counseling for reducing smoking in pregnancy. This randomized controlled pilot study evaluated feasibility and potential efficacy of a social-cognitive theory (SCT)-based biomarker feedback intervention among pregnant Alaska Native (AN) smokers. Methods: Participants were randomly assigned to receive three study calls (10–20 min each): (1) biomarker feedback intervention (n = 30) including personalized cotinine results and feedback on their baby's likely exposure to carcinogen metabolite NNAL, or (2) contact control usual care condition based on the 5As (n = 30). Assessments were conducted at baseline, post-treatment, and delivery. Results: High rates of treatment compliance, study retention, and treatment acceptability were observed in both groups. 7-day point prevalence smoking abstinence rates at delivery verified with urinary cotinine were the same in both study groups (20% intent-to-treat analysis, 26% per-protocol). SCT-based measures did not change differentially from baseline by study group. Conclusion: This trial supports the feasibility and acceptability of providing biomarker feedback within the clinical care delivery system, but the intervention did not promote increased smoking cessation during pregnancy compared to usual care. Practice Implications: Efforts are needed to promote the usual care and to develop alternative biomarker feedback messaging for pregnant AN women.

KW - Alaska Native

KW - Biomarker feedback

KW - Cigarette smoking

KW - Intervention

KW - Pregnancy

KW - Smoking cessation

UR - http://www.scopus.com/inward/record.url?scp=85055750700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055750700&partnerID=8YFLogxK

U2 - 10.1016/j.pec.2018.10.009

DO - 10.1016/j.pec.2018.10.009

M3 - Article

C2 - 30391300

AN - SCOPUS:85055750700

SN - 0738-3991

VL - 102

SP - 528

EP - 535

JO - Patient Education and Counseling

JF - Patient Education and Counseling

IS - 3

ER -

Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this